Research Brief: Octapharma IVIg Iffy in Phase 2 Trial
Inc.; CSL Behring; and Sutter Health (see ARF related conference story).—Esther Landhuis None
379 RESULTS
You searched Esther
Sort By:
Inc.; CSL Behring; and Sutter Health (see ARF related conference story).—Esther Landhuis None
York Times story). The league also has a new website focusing on health and safety.—Esther Landhuis.
meaningful analysis,” Zerr said.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=3402
additional search strategy content for head injury.—Esther Landhuis. None
as frontotemporal dementia.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3387
skills, language, and memory development.—Esther Landhuis None
therapeutic window is much longer [for mini-strokes].”—Esther Landhuis None
interested in how hypometabolism stresses their brains and what goes on while they are thinking.—Esther
story; EPOCH). Q&A With Johan Luthman. Questions by Esther Landhuis. Q: ClinicalTrials.gov says the
(Becker et al., 2011).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3342
inhibitors.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=3339 Alzheimer's Disease Biomarkers
understand how Aβ alters clusterin trafficking and how the Aβ Dkk1 target genes mediate cell death.—Esther
story).—Esther Landhuis. Reference: Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, Soininen
could spread to blood vessels and affect white matter change through a CAA route.—Esther Landhuis None
of fragile X syndrome, the most common genetic cause of autism (Jung et al., 2012).—Esther Landhuis